4Walker R. Diabetes and peripheral neuropathy: Keeping people on their own two foot[J]. Br J Community Nurs, 2005,10 : 33 - 36.
5Bianchi L, Ginebri A, Hagman J H, et al. Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte - macrophage colony - stimulating factor [J]. JEADV, 2002 ( 16 ) : 595 - 598.
6Reiber GE. Epidemiology and health care costs of diabetic foot problems[M]//Veves A. The diabetic foot: Medical and surgical management. New Jersey: Humana, 2002 : 58.
4Karmaker M, Sanyal SK, Sultana M, et al. Association of bacteria in diabetic and non-diabetic foot infection - an investigation in patients from Bangladesh. J Infect Public Health. 2015.
5Silva RN, Ferreira AC, Ferreira DD, et al. Non-invasive method to analyse the risk of developing diabetic foot. Healthc Technol Lett. 2014;1(4):109-113.
6EI-Naggar MY, Gohar YM, Sorour MA, et al. Hydrogel dressing with a nano-formula against methicillin-resistant S aureus and P. aeruginosa diabetic foot bacteria. J Microbiol Biotechnol. 2015.
7Mamo T, Yifter H, Lemessa T. Risk factors assessment of diabetic foot ulcer using the sixty seconds screening tool: a hospital based cross-sectional study at tikur anbessa specialized hospital. Ethiop Med J. 2015;Suppl 2:45-49.
8Pavlovich KV, Sydorchuk RI. Injecting material for skin regeneration lacerta application in treatment of trophic ulcers in patients with diabetic foot syndrome.Klin Khir. 2015;(7): 44-46.
9Petrenko OM Role of ultrasonic cavitation in complex treatment of suppurative-necrotic complications of diabetic foot syndrome. Klin Khir. 2015;(7):41-43.
10Mrozikiewicz-Rakowska B, Maroszek P, et al. Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. J Physiol Pharmacol. 2015;66(5):751-761.
